Colorectal cancer and country of birth in New South Wales, Australia: All-of-population data for prioritising health service delivery and research.


Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
10 2022
Historique:
received: 03 07 2022
revised: 15 08 2022
accepted: 21 08 2022
pubmed: 30 8 2022
medline: 21 9 2022
entrez: 29 8 2022
Statut: ppublish

Résumé

Cancer care and outcomes differ across cultural groups in Australia. Quantifying these differences facilitates prioritisation and targeting of services and research. All-of-population data are needed by health agencies to understand and fulfil their cancer-control responsibilities. Compiling these data can be challenging while maintaining privacy. We have used data linkage to gain population-wide colorectal cancer data on stage (degree of spread), treatment, and survival in New South Wales (NSW), Australia, by country of birth (COB), and consider service implications. We studied colon and rectal cancers diagnosed in 2003-2016 and recorded on the NSW Cancer Registry (n = 41,575), plus linked hospital data and data from Australian Medical and Pharmaceutical Benefits payments, other treatment data and death records. Outcomes for 12 COB categories were analysed using multiple logistic and proportional hazards regression, with Australia as the reference category. Compared with Australian born, the adjusted odds ratio for distant spread of colon cancer was higher for people born in Lebanon and the United Kingdom. Treatment was less common for people born in China (surgery), Germany (systemic), Italy (surgery), New Zealand (any treatment) and Vietnam (all treatments), while treatment for rectal cancer was more common for people born in Italy (surgery), United Kingdom (radiotherapy, systemic therapy), and Vietnam (surgery), and less frequent for people born in China (radiotherapy). Adjusted 5-year survival was higher for people born in China, Italy, Vietnam, Greece (colon), Lebanon (colon) and other non-English speaking countries. More advanced stage was negatively related to having surgery and survival. This study illustrates how linked data can enable comparisons of multiple outcomes for colorectal cancer by country of birth across an entire population. Results disclose "big picture" variations in population characteristics, stage, treatment and survival. This will enable better targeting and prioritisation of services and inform research priorities to address disparities.

Identifiants

pubmed: 36037560
pii: S1877-7821(22)00148-5
doi: 10.1016/j.canep.2022.102243
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102243

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Competing interests The authors declare that they have no competing interests.

Auteurs

George W Zhao (GW)

Cancer Information and Analysis, Cancer Institute New South Wales, St Leonards, NSW 2065, Australia.

David M Roder (DM)

Cancer Information and Analysis, Cancer Institute New South Wales, St Leonards, NSW 2065, Australia. Electronic address: david.roder@unisa.edu.au.

Sarah White (S)

Cancer Information and Analysis, Cancer Institute New South Wales, St Leonards, NSW 2065, Australia.

Enmoore Lin (E)

Cancer Information and Analysis, Cancer Institute New South Wales, St Leonards, NSW 2065, Australia.

Sheetal Challam (S)

Equity, Multicultural Program, Cancer Institute New South Wales, St Leonards, NSW 2065, Australia.

Alana Little (A)

Cancer Information and Analysis, Cancer Institute New South Wales, St Leonards, NSW 2065, Australia.

Andre Renzaho (A)

Translational Health Research Institute, Western Sydney University, Campbelltown, NSW 2560, Australia.

Leissa Pitts (L)

Multicultural and Refugee Health Service, Illawarra Shoalhaven LHD, Warrawong, NSW 2502, Australia.

Winston Liauw (W)

Cancer Care Centre, St George Hospital, Kogarah, NSW 2217, Australia.

David Currow (D)

Health and Sustainable Futures, University of Wollongong, Wollongong, NSW 2500, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH